Samuel Gershon: Ketamine, the "new" breakthrough in the trestment of depression


Samuel Gershon’s reply to Ken Gillman’s comment on his reply to David

Janowsky and Edward Shorter’s comment


        I have read these comments carefully and can only say that my views are entirely in accord with Ken Gillman on his essay on ketamine contributions from David Janowsky and Edward Shorter.

        It may be with this block buster compound that its block buster claims will need revision after some good  studies of  uniform diagnostic patients are carried out and carefully and critically reviewed.

        We have had some history of big bangs entering into psychiatric treatment and their slow, quiet and secret withdrawal from the field.


March 4, 2021